表紙
市場調查報告書

放射性醫藥品/核醫學的全球市場:產業分析,規模,佔有率,成長、 趨勢,預測(2019年∼2026年)

Global Radiopharmaceutical/Nuclear Medicine Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

出版商 Value Market Research 商品編碼 954533
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
放射性醫藥品/核醫學的全球市場:產業分析,規模,佔有率,成長、 趨勢,預測(2019年∼2026年) Global Radiopharmaceutical/Nuclear Medicine Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026
出版日期: 2020年08月01日內容資訊: 英文 190 Pages
簡介

本報告提供全球放射性醫藥品/核醫學市場的相關調查,提供市場成長及阻礙因素,課題,機會,影響,類型·用途·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 產業分析

  • 簡介
  • 市場成長要素
  • 阻礙市場要素
  • 市場機會
  • 市場趨勢
  • 波特的五力分析
  • 市場魅力分析

第4章 價值鏈分析

  • 價值鏈分析
  • 原料分析
  • 潛在的買主清單
  • 行銷流通管道

第5章 市場分析:各類型

  • 概要
  • 全球市場分析
  • 診斷
  • 治療

第6章 市場分析:各用途

  • 概要
  • 全球市場分析
  • 診斷用途
  • 治療用途

第7章 市場分析:各地區

  • 地區預測
  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭情形

  • 放射性醫藥品/核醫學市場競爭
  • 聯盟/合作/契約
  • 合併和收購
  • 新產品的銷售
  • 其他開發

第9章 企業簡介

  • 企業佔有率分析
  • 市場集中率
  • Advanced Accelerator Applications
  • Bayer
  • Bracco Imaging
  • Cardinal Health
  • Curium
  • Eczacibasi-Monrol Nuclear Products
  • Ge Healthcare
  • Lantheus Medical Imaging
  • Nordion

第10章 COVID-19疫情爆發的影響分析

  • Covid-19疫情爆發的影響分析
  • 對生產,進出口,需求的影響分析
  • COVID-19疫情爆發前後的市場
  • 各方案估計2020年的市場影響
  • 市場微觀和宏觀因素分析
目錄

Value Market Research's latest report on the Global Radiopharmaceutical/Nuclear Medicine Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2020-2026.

The global radiopharmaceutical/nuclear medicine market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global radiopharmaceutical/nuclear medicine market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global radiopharmaceutical/nuclear medicine market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global radiopharmaceutical/nuclear medicine market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global radiopharmaceutical/nuclear medicine market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global radiopharmaceutical/nuclear medicine market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global radiopharmaceutical/nuclear medicine market.

The market analysis involves a section exclusively to list the major players of the global radiopharmaceutical/nuclear medicine market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Radiopharmaceutical/Nuclear Medicine Market Report Segments the market as below -

By Type

  • Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • PETRadiopharmaceuticals
  • Therapeutic Nuclear Medicine
  • Alpha Emitters
  • Beta Emitters
  • Brachytherapy Isotopes

By Application

  • Diagnostic Application
  • SPECT Application
  • Cardiology
  • Lymphoma
  • Neurology
  • Thyroid
  • Other
  • PET Application
  • Oncology
  • Cardiology
  • Neurology
  • Other
  • Therapeutic Application
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumor
  • Other Therapeutic Application

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Radiopharmaceutical/Nuclear Medicine Market
  • 2.2. Global Radiopharmaceutical/Nuclear Medicine Market Snapshot

3 . RADIOPHARMACEUTICAL/NUCLEAR MEDICINE - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Radiopharmaceutical/Nuclear Medicine Market
  • 3.3. Market Restraints of Radiopharmaceutical/Nuclear Medicine Market
  • 3.4. Opportunities of Radiopharmaceutical/Nuclear Medicine Market
  • 3.5. Trends of Radiopharmaceutical/Nuclear Medicine Market
  • 3.6. Porter's Five Force Analysis of Radiopharmaceutical/Nuclear Medicine Market
  • 3.7. Radiopharmaceutical/Nuclear Medicine Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Type
    • 3.7.2 Market Attractive Analysis by Application
    • 3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Radiopharmaceutical/Nuclear Medicine Value Chain Analysis
  • 4.2. Radiopharmaceutical/Nuclear Medicine Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Radiopharmaceutical/Nuclear Medicine Raw Material Manufactures List
    • 4.2.3. Price Trend of Radiopharmaceutical/Nuclear Medicine Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Global Radiopharmaceutical/Nuclear Medicine Market Analysis by Type
  • 5.3 Market Analysis of Diagnostic Nuclear Medicine by Regions
  • 5.4 Market Analysis of Therapeutic Nuclear Medicine by Regions

6 . GLOBAL RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Global Radiopharmaceutical/Nuclear Medicine Market Analysis by Application
  • 6.3 Market Analysis of Diagnostic Application by Regions
  • 6.4 Market Analysis of Therapeutic Application by Regions

7 . GLOBAL RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America
    • 7.3.1. Overview
    • 7.3.2. North America Radiopharmaceutical/Nuclear Medicine Market Estimate by Market Segment
    • 7.3.3. North America Radiopharmaceutical/Nuclear Medicine Market Estimate by Country
    • 7.3.4. United State
    • 7.3.5. Rest of North America
  • 7.4. Europe
    • 7.4.1. Overview
    • 7.4.2. Europe Radiopharmaceutical/Nuclear Medicine Market Estimate by Market Segment
    • 7.4.3. Europe Radiopharmaceutical/Nuclear Medicine Market Estimate by Country
    • 7.4.4. United Kingdom
    • 7.4.5. France
    • 7.4.6. Germany
    • 7.4.7 Rest of Europe
  • 7.5. Asia Pacific
    • 7.5.1. Overview
    • 7.5.2. Asia Pacific Radiopharmaceutical/Nuclear Medicine Market Estimate by Market Segment
    • 7.5.3. Asia Pacific Radiopharmaceutical/Nuclear Medicine Market Estimate by Country
    • 7.5.4. China
    • 7.5.5. Japan
    • 7.5.6. India
    • 7.5.7. Rest of Asia Pacific
  • 7.6. Latin America
    • 7.6.1. Overview
    • 7.6.2. Latin America Radiopharmaceutical/Nuclear Medicine Market Estimate by Market Segment
    • 7.6.3. Latin America Radiopharmaceutical/Nuclear Medicine Market Estimate by Country
    • 7.6.4. Brazil
    • 7.6.5. Rest of Latin America
  • 7.7. Middle East & Africa
    • 7.7.1. Overview
    • 7.7.2. Middle East & Africa Radiopharmaceutical/Nuclear Medicine Market Estimate by Market Segment
    • 7.7.3. Middle East & Africa Radiopharmaceutical/Nuclear Medicine Market Estimate by Country
    • 7.7.4. Middle East
    • 7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE RADIOPHARMACEUTICAL/NUCLEAR MEDICINE COMPANIES

  • 8.1. Radiopharmaceutical/Nuclear Medicine Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF RADIOPHARMACEUTICAL/NUCLEAR MEDICINE INDUSTRY

  • 9.1. Company Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Advanced Accelerator Applications
    • 9.3.1. Company Overview
    • 9.3.2. Financials
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Bayer
    • 9.4.1. Company Overview
    • 9.4.2. Financials
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Bracco Imaging
    • 9.5.1. Company Overview
    • 9.5.2. Financials
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Cardinal Health
    • 9.6.1. Company Overview
    • 9.6.2. Financials
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Curium
    • 9.7.1. Company Overview
    • 9.7.2. Financials
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Eczacibasi-Monrol Nuclear Products
    • 9.8.1. Company Overview
    • 9.8.2. Financials
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Ge Healthcare
    • 9.9.1. Company Overview
    • 9.9.2. Financials
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Lantheus Medical Imaging
    • 9.10.1. Company Overview
    • 9.10.2. Financials
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Nordion
    • 9.11.1. Company Overview
    • 9.11.2. Financials
    • 9.11.3. Products
    • 9.11.4. Recent Developments

10. IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 10.1. Impact Analysis of Covid-19 Outbreak on the Market
    • 10.1.1. Direct Impact on Production
    • 10.1.2. Supply Chain and Market Disruption
    • 10.1.3. Financial Impact on Firms and Financial Markets
  • 10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 10.3. Pre V/S Post COVID-19 Market
  • 10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
  • 10.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Diagnostic Nuclear Medicine by Geography (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Therapeutic Nuclear Medicine by Geography (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis by Application (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Diagnostic Application by Geography (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Therapeutic Application by Geography (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market by Geography (USD MN)
  • North America Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • North America Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • North America Radiopharmaceutical/Nuclear Medicine Market Estimate by Country (USD MN)
  • United State Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • United State Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Rest of North America Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Rest of North America Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Europe Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Europe Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • United Kingdom Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • United Kingdom Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • France Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • France Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Germany Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Germany Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Rest of Europe Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Rest of Europe Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Asia Pacific Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Asia Pacific Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Asia Pacific Radiopharmaceutical/Nuclear Medicine Market Estimate by Country (USD MN)
  • China Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • China Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Japan Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Japan Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • India Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • India Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Rest of Asia Pacific Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Latin America Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Latin America Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Latin America Radiopharmaceutical/Nuclear Medicine Market Estimate by Country (USD MN)
  • Brazil Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Brazil Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Rest of Latin America Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Rest of Latin America Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Middle East & Africa Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Middle East & Africa Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Middle East & Africa Radiopharmaceutical/Nuclear Medicine Market Estimate by Country (USD MN)
  • Middle East Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Middle East Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Africa Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Africa Radiopharmaceutical/Nuclear Medicine Market Estimate by Application (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019

LIST OF FIGURES

  • Research Scope of Radiopharmaceutical/Nuclear Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Radiopharmaceutical/Nuclear Medicine Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis by Type (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Diagnostic Nuclear Medicine by Geography (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Therapeutic Nuclear Medicine by Geography (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis by Application (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Diagnostic Application by Geography (USD MN)
  • Global Radiopharmaceutical/Nuclear Medicine Market Analysis in Therapeutic Application by Geography (USD MN)
  • Latin America Radiopharmaceutical/Nuclear Medicine Market by Revenue
  • Middle East & Africa Radiopharmaceutical/Nuclear Medicine Market by Revenue
  • Recent Development in Radiopharmaceutical/Nuclear Medicine Industry
  • Company Market Share Analysis, 2019
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.